Senior Validation Engineer (I, II, III)

We are seeking a Senior Validation Engineer with solid hands-on validation experience and a collaborative mindset to help drive validation harmonization across the Cellares global landscape.  
 
The primary focus of this position will be responsible for execution activities for QC and Manufacturing equipment.  In addition to many of the equipment seen at traditional cell & gene therapy facilities, this position will focus on the qualification and validation of several Cellares proprietary equipment.  Thus the ideal candidate for this position will have not only a deep understanding of qualification and validation lifecycle activities across all manufacturing process streams, but also have the ability to apply that knowledge base to the Cellares Cell Shuttle and Cell Q.   In addition to equipment qualification and validation, the person in this position will also execute facilities and utility systems. The desired candidate will be very hands-on with execution, but also develop documentation; validation/qualification protocols (IQ/OQ/PQ), risk assessments, system impact assessments, summary reports, SOPs and other technical documents. This position, at times, will require the oversight of contract workers, junior level engineers and equipment vendors. 

Candidates should enjoy working in a fast-paced, mission-driven environment, be comfortable with using justified risk based approaches, and be prepared to tackle a broad selection of challenges as the company grows.

Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.

The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.